B. Riley Wealth Advisors Inc. Purchases 1,770 Shares of Kenvue Inc. (NYSE:KVUE)

B. Riley Wealth Advisors Inc. raised its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 7.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,210 shares of the company’s stock after acquiring an additional 1,770 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Kenvue were worth $586,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in KVUE. Stephens Inc. AR lifted its stake in Kenvue by 86.1% in the 4th quarter. Stephens Inc. AR now owns 57,694 shares of the company’s stock worth $1,242,000 after purchasing an additional 26,700 shares in the last quarter. Stifel Financial Corp grew its holdings in Kenvue by 60.4% during the 4th quarter. Stifel Financial Corp now owns 745,064 shares of the company’s stock valued at $16,041,000 after buying an additional 280,591 shares in the last quarter. Raleigh Capital Management Inc. grew its holdings in Kenvue by 93,834.8% during the 4th quarter. Raleigh Capital Management Inc. now owns 43,210 shares of the company’s stock valued at $930,000 after buying an additional 43,164 shares in the last quarter. Fifth Third Bancorp increased its stake in Kenvue by 35.3% in the 4th quarter. Fifth Third Bancorp now owns 277,580 shares of the company’s stock worth $5,976,000 after acquiring an additional 72,435 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its stake in Kenvue by 2.6% in the 4th quarter. The Manufacturers Life Insurance Company now owns 1,598,567 shares of the company’s stock worth $34,417,000 after acquiring an additional 40,995 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on KVUE. William Blair started coverage on shares of Kenvue in a research report on Wednesday, April 3rd. They issued a “market perform” rating on the stock. HSBC upped their price objective on Kenvue from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Citigroup restated a “neutral” rating and set a $21.00 price target on shares of Kenvue in a report on Tuesday, May 28th. The Goldman Sachs Group assumed coverage on shares of Kenvue in a research note on Friday, March 1st. They set a “neutral” rating and a $20.00 price objective for the company. Finally, Sanford C. Bernstein initiated coverage on shares of Kenvue in a research note on Thursday, April 11th. They issued an “underperform” rating and a $18.00 target price on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Kenvue currently has an average rating of “Hold” and a consensus target price of $23.09.

Kenvue Stock Down 1.6 %

Shares of NYSE:KVUE opened at $18.53 on Friday. The business’s 50 day moving average is $19.27 and its 200 day moving average is $20.04. The stock has a market cap of $35.48 billion and a P/E ratio of 23.76. Kenvue Inc. has a 52-week low of $17.75 and a 52-week high of $26.74. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.03. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $3.79 billion. Kenvue had a return on equity of 21.06% and a net margin of 9.63%. The business’s revenue was down 24.9% compared to the same quarter last year. Sell-side analysts predict that Kenvue Inc. will post 1.17 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 22nd. Stockholders of record on Wednesday, May 8th were given a $0.20 dividend. The ex-dividend date of this dividend was Tuesday, May 7th. This represents a $0.80 annualized dividend and a dividend yield of 4.32%. Kenvue’s payout ratio is presently 102.56%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.